Source
Y Combinator Startup Podcast — How The Best Companies Defend Against Mediocrity And Rot (May 25, 2026) ·
at 34:28 ▸ ·
at 38:35 ▸
When this applies
when building a for-profit enterprise around something people will become dependent on, where future leadership might be tempted to exploit that dependence
The takeaway
Splitting mission-guardianship (nonprofit trustees) from operational/financial management (for-profit directors) into two entities can let the mission veto value-destroying 'best practice' moves (like unnecessary mergers) that a single-entity board would have approved.
Why it works
By creating a nonprofit foundation with trustees whose sole mandate is protecting the mission, and a separate for-profit subsidiary run by directors, major decisions (like a merger) require the trustees' sign-off against a strict mission-survival test — insulating the company from 'best practice' pressure like consolidation waves.
One level up
Separating the guardianship function from the operational function creates a check that a unified structure cannot provide.
Where it stops holding
This stops working when the nonprofit trustees themselves get captured by the same pressures (not evidenced here, but theoretically possible), or when regulatory environments don't permit such dual structures.
Detail
situation: Marie and August Krogh licensed insulin from Canadian discoverers, worried about future price-gouging by a for-profit monopoly on a life-saving drug, so structured a nonprofit foundation owning a for-profit subsidiary (predecessor to Novo Nordisk).
decision: Decades later, when the for-profit board wanted to merge amid a pharma consolidation wave, the foundation's trustees required proof the merger was 'necessary for survival'; finding the company profitable and growing 20%/year, they rejected the merger.
outcome: The GLP-1 research program (year 11 of 13, no proof of success yet) was preserved; the would-be merger partner was later acquired by Merck and had its R&D cut; Novo Nordisk's market cap later crested around $600 billion, at times exceeding Denmark's GDP.
lesson: A structural mission-guardian (nonprofit trustees) blocking a 'necessary' merger preserved long-shot R&D that became immensely valuable — a counterfactual rarely visible in business.
In their words
We're only allowed to approve a merger if it's necessary for the survival of the company.